Cystic Fibrosis Transmembrane Conductance Regulator Regulates Epithelial Cell Response to Aspergillus and Resultant Pulmonary Inflammation
Open accessAbstract
Rationale: Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) alter epithelial cell (EC) interactions with multiple microbes, such that dysregulated inflammation and injury occur with airway colonization in people with cystic fibrosis (CF). Aspergillus fumigatus frequently colonizes CF airways, but it has been assumed to be an innocent saprophyte; its potential role as a cause of lung disease is controversial. Objectives: To study the interactions between Aspergillus and EC, and the role of the fungus in evoking inflammatory responses. Methods: A. fumigatus expressing green fluorescent protein was developed for in vitro and in vivo models, which used cell lines and mouse tracheal EC. Measurements and Main Results: Fungal spores (conidia) are rapidly ingested by ECs derived from bronchial cell lines and murine tracheas, supporting a role for EC in early airway clearance. Bronchial ECs harboring CFTR mutations (ΔF508) or deletion demonstrate impaired uptake and killing of conidia, and ECs with CFTR mutation undergo more conidial-induced apoptosis. Germinated (hyphal) forms of the fungus evoke secretion of inflammatory mediators, with CFTR mutation resulting in increased airway levels of macrophage inflammatory protein 2 and KC, and higher lung monocyte chemotactic protein-1. After A. fumigatus inhalation, CFTR−/− mice develop exaggerated lymphocytic inflammation, mucin accumulation, and lung injury. Conclusions: Data demonstrate a critical role for CFTR in mediating EC responses to A. fumigatus. Results suggest that the fungus elicits aberrant pulmonary inflammation in the setting of CFTR mutation, supporting the potential role of antifungals to halt progressive CF lung disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mutations in CFTR receptors observed in cystic fibrosis were associated with defective uptake and killing of Aspergillus conidia by ECs and with subsequent deregulated inflammatory responses.
“Mutations in CFTR receptors observed in cystic fibrosis were associated with defective uptake and killing of Aspergillus conidia by ECs and with subsequent deregulated inflammatory responses (224).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [224]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 48 · Cited by 79
- Authors
- Chaudhary, N., Datta, K., Askin, F. B., Staab, J. F., & Marr, K. A.
- Affiliations
- Johns Hopkins University (US)
- Department of Medicine and
- Sidney Kimmel Comprehensive Cancer Center (US)
- Corresponding author
- Marr, Kieren A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-02-01
- Volume
- 185
- Issue
- 3
- Pages
- 301-310
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC5448574
- OpenAlex
- W2069385439
- Cited by
- 79
- References
- 48
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 5 · 2018: 7 · 2017: 7 · 2016: 9 · 2015: 2 · 2014: 6 · 2013: 7 · 2012: 3
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P30CA006973)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK027651)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- cystic fibrosis, CFTR, Aspergillus fumigatus, epithelial cells, lung inflammation, apoptosis, CXCL2, KC, MCP-1, lymphocytic inflammation, mucin accumulation, lung injury, antifungal therapy, CFTR mutations
- MeSH terms
- Animals, Aspergillosis, Aspergillus fumigatus, Bronchi, Cell Line, Cystic Fibrosis, Epithelial Cells, Flow Cytometry, Immunity, Cellular, Inflammation, Lung, Mice, Inbred C57BL, Trachea, Cytokines, Apoptosis, Mice, Knockout, Cystic Fibrosis Transmembrane Conductance Regulator, Respiratory Mucosa, Mice, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review